Inactive Instrument

News Galapagos NV Euronext Bruxelles

Stocks

GLPG

BE0003818359

Biotechnology & Medical Research

End-of-day quote Euronext Bruxelles Other stock markets
-	-

07-14	Lakefront Biotherapeutics NV Announces Resignation of Paulo Fontoura as Director	CI
06-17	Lakefront Biotherapeutics NV commences an Equity Buyback for 10% of its issued share capital, under the authorization approved on April 28, 2026.	CI

All News

Mentions Relevance

07-29	Acquisition of Own Shares	GL
07-22	Acquisition of Own Shares	GL
07-15	Acquisition of Own Shares	GL
07-14	Lakefront Biotherapeutics NV Announces Resignation of Paulo Fontoura as Director	CI
07-14	Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi	GL
07-08	Acquisition of Own Shares	GL
07-01	Acquisition of Own Shares	GL
06-30	Lakefront Receives Transparency Notification from Madison Avenue Partners	GL
06-24	Acquisition of Own Shares	GL
06-17	Lakefront Biotherapeutics NV - Acquisition of Own Shares	AQ
06-17	Lakefront Biotherapeutics NV commences an Equity Buyback for 10% of its issued share capital, under the authorization approved on April 28, 2026.	CI
06-17	Acquisition of Own Shares	GL
06-10	Lakefront Announces Share Buyback Program
06-10	Lakefront Biotherapeutics Kicks Off Up to EUR50 Million Share Buyback Program	MT
06-10	Lakefront Biotherapeutics Launches 50 Million Euros Share Repurchase Program	MT
06-10	Lakefront Announces Initiation of €50 Million Stock Repurchase Program	GL
06-09	Lakefront Biotherapeutics Names New Chief Medical Officer	MT
06-09	Lakefront Biotherapeutics Names Eric Hedrick as Chief Medical Officer	MT
06-09	Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer	GL
06-09	Lakefront Biotherapeutics NV Announces Appointment of Eric Hedrick as Chief Medical Officer	CI
06-05	Lakefront Biotherapeutics and Gilead Sciences Finalize Acquisition
06-05	Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline	BU
06-05	GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE	GL
05-27	Lakefront receives transparency notification from Bank of America	RE
05-27	Lakefront Receives Transparency Notification from Bank of America	GL